Los Angeles, Dec. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — R-Three Technologies, Inc. (OTC Symbol RRRT): R3T is pleased to announce that Dr. Hamid Alizadeh and Dr. David M. Snipper agreed to join the R3T Advisory Board. The addition of the doctors to the advisory board strengthens the company’s health and wellness offerings.
Dr. Alizadeh was an ER specialist and MD for 10 years before he gave up his practice to move into the world of finance. As an ER specialist, he treated patients from all walks of life. When he treated his patients he not only wanted to get rid of their current malady but wanted to look and see what else he could do to prolong their lives. This was the genesis of his interest in overall wellness. When he retired from medicine to pursue a career in finance many thought that was a risky move. His background in medicine coupled with his bedside manner allowed him to quickly attract clients so that he could create healthy long-term portfolios indexed to market and married with an insurance wrapper. As a wealth manager, he now manages over 1000 clients and has trained and supervised a number of referring agents. He currently has $50 million in assets under management. It is expected that Dr. Alizadeh will be able to utilize his expertise in wellness to further advance the development of beverage and wellness products coming out of the beverage division. He loves team building and understands the financial markets.
“The people on this team are top-notch,” said Dr. Hamid Alizadeh. “Having a chance to interact with both Keith Hasting a former VP of Wells Fargo who shares my background and Peter Van Brunt J.D. showed me how in synch we are as a team. The two board additions of Bruce and David Langer are major wins for us. There is no reason why we can’t become a powerhouse in the wellness industry with this depth of talent. My vision for future offerings is a healthy drink that prolongs life and is not filled with sugar and caffeine like most drinks. I look forward to contributing where I can.”
Dr. David M. Snipper started his career as an anesthesiologist who graduated from the University of San Diego School of Medicine and completed his residency at UC Irvine Medical Center. He remained on staff in a teaching position as Assistant Clinical Professor and Director of the Pain Management Program. In that role, he also published several research articles relating to the multi-disciplinary approach to the treatment of complex pain disorders. He moved to Las Vegas to run a private practice of anesthesiology and ultimately became a partner at the largest group in Nevada. During his tenure, he served as medical director of several surgery centers. After a decade of practice, he became disenfranchised with the big pharm approach to healing and started studying herbal medicine and holistic healing. This path eventually led him to form a company called Global Green Sciences, whose mission statement was to advance healthcare by taking a new approach. New and old medicine would combine and then be practiced using compassion with respect to science and technology. He currently manages 2 clinics in Las Vegas.
“I have to thank Lance for bringing me on board to join this team of industrious individuals,” said Dr. David Snipper. “I am honored and ready to use my unique skill set to help in any way that I can to move our projects along. At my core, I am a healer that wants to find cures and not just treat symptoms. I am excited to be here because I believe R3T is a great platform for me to leverage the number of people that can be touched by my experience in the field.”
“The team is really coming together,” said Stan Kolaric, CEO of R3T. “These recent adds to our advisory board should help us round out our upcoming product offerings this year and develop our next generation of products. The true measure of a team is how they work in unison. When we work together it’s not like we can finish each other’s sentences but we all have different points of view that can all see the primary vision clearly. We have a couple more people to announce, but our roster is definitely looking up.”
About R-Three Technologies Inc.
R Three Technologies is an early-stage development company with a success-driven Board which is focused on carefully pursuing several ventures it believes shows tremendous potential in development and manufacture of food and drink products. We are currently pursuing our options with a successful Juice Company within the beverage industry to formulate consumer products for large-scale distribution.
This press release includes several forward-looking statements that reflect Management’s current views with respect to future events and financial performance. You can identify these statements by words such as “may”, “will”, “expect”, “anticipate”, “believe”, “estimate”, and “continue” or similar words. Those statements include statements regarding the intent, belief or current expectations of us and members of our management team as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forwarding look statements. Readers are urged to carefully review and consider the various disclosures made by us in this press release and our filings as posted on the OTC Markets with the Securities and Exchange Commission. Important factors currently known to Management could cause actual results to differ materially from those in forward-looking statements. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in reasonable data derived from and known about our business and operations.
Former Barron’s Roundtable member Felix Zulauf sees the S&P falling by a third, aiding traders and terrifying buy-and-holders. How he’d protect portfolios.
As large organizations gather more data, they'll need more artificial intelligence (AI) tools to process and analyze all that information. Today I'll examine three companies that leverage AI technologies to simplify tasks for government agencies, large corporations, and individual consumers, and why their stocks might be solid long-term investments. Palantir (NYSE: PLTR) gathers and organizes data from disparate sources to help its clients make data-driven decisions.
Ackman blames the government's “extremely imprecise” metrics for underestimating costs.
Buffett turned millions into billions without relying on Tesla or Rivian. Here's how.
In this article, we discuss the 10 cheap semiconductor stocks to invest in today. If you want to skip our detailed analysis of these stocks, go directly to the 5 Cheap Semiconductor Stocks to Invest In Today. Data released by World Semiconductor Trade Statistics reveals that global semiconductor sales will top $600 billion in 2022, […]
Expectations for higher interest rates have triggered a reversal in pricey growth stocks, and it’s likely not over yet.
FEATURES – MAIN The U.S. stock market hasn’t followed the script in 2021. The index returned 26% through Dec. 16, well ahead of the roughly 10% gain projected, on average, by strategists at the start of the year.
If you haven't heard about the saver's credit, you may be leaving cash on the table.
Looking to buy some stocks in the New Year? Here are 11 names to consider from Bank of America.
Nio's stock might be struggling to navigate macroeconomic concerns, but the EV maker is focused on what matters.
Shares prices of Rivian Automotive (NASDAQ: RIVN) are hovering around a 52-week low after the electric truck, SUV, and delivery van manufacturer reported its first quarterly earnings as a public company. Let's unpack the earnings report to determine what's driving Rivian's stock lower right now. Rivian's goal was to produce 1,200 vehicles by the end of the year after delivering its first R1T truck in September.
With yields ranging from 5% to 9%, these stocks are no-brainers that will compound dividend growth for decades to come.
The market rally is chopping up investors financially and mentally, Nio Day showcased two EV sedans to take on Tesla.
Altria Group, Inc. ( NYSE:MO ) stock is about to trade ex-dividend in four days. The ex-dividend date is one business…
Upstart Holdings (NASDAQ: UPST) has been one of the biggest stock stories of the year. Upstart uses artificial intelligence (AI) to evaluate a borrower's credit risk. This scoring method places a great emphasis on the prospective borrower's payment history, and it also looks at amounts owed, types of credit, length of credit history, and recent credit activity.
The stock of Teladoc Health (NYSE: TDOC) exploded higher on Friday, up 11.8% as of 12:20 p.m., as shares of the telemedicine pioneer struggled to defy a downtrend that has cost the company a staggering 66% of its market capitalization since February this year. The jump could be a result of a dire warning from President Joe Biden yesterday, or in the longer term, the potential to expand the business internationally. The first and most obvious reason: President Biden held a press conference yesterday featuring the chilling warning that America is facing a "winter of severe illness and death."
QuantumScape announced a new business partner—an unidentified luxury auto maker that is interested in the startup's EV battery technology.
The decline was more than the drop in the broader sector as the KBW Nasdaq Bank Index, which tracks large bank stocks, only fell about 3% today. The bank sector came under pressure today as the yield on the 10-year U.S. Treasury bill fell ever so slightly, while the yield on the two-year U.S. Treasury bill rose slightly.
Here's another cold, hard truth that many proponents of penny stocks don't tell you: Many low-priced shares stay low for a very long time.
After falling by at least a third over the past month, these former highfliers are poised to reach new heights in the new year.